Figure 3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

Figure 3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

<p><i>TP53</i> gene mutation prediction from H&E images. <b>A,</b> Workflow for deep learning of <i>TP53</i> mutations from FN-RMS WSIs. <b>B</b> and <b>C,</b> Representative (<b>B</b>) H&E images and (<b>C&l...

Volledige beschrijving

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	David Milewski (15050643) (author)
Andere auteurs:	Hyun Jung (15050646) (author), G. Thomas Brown (15050649) (author), Yanling Liu (15050652) (author), Ben Somerville (15050655) (author), Curtis Lisle (15050658) (author), Marc Ladanyi (15050661) (author), Erin R. Rudzinski (15050664) (author), Hyoyoung Choo-Wosoba (15050667) (author), Donald A. Barkauskas (15050670) (author), Tammy Lo (15050673) (author), David Hall (15050676) (author), Corinne M. Linardic (15050679) (author), Jun S. Wei (14955721) (author), Hsien-Chao Chou (14955718) (author), Stephen X. Skapek (15050682) (author), Rajkumar Venkatramani (15050685) (author), Peter K. Bode (15050688) (author), Seth M. Steinberg (15043179) (author), George Zaki (15050691) (author), Igor B. Kuznetsov (15050694) (author), Douglas S. Hawkins (15050697) (author), Jack F. Shern (14938001) (author), Jack Collins (15050700) (author), Javed Khan (15046967) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Prognostic biomarkers Computational Methods Artificial intelligence & machine learning Pediatric Cancers Sarcomas Soft-tissue sarcoma
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Figure 1 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
door: David Milewski (15050643)
Gepubliceerd in: (2025)

Figure 2 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
door: David Milewski (15050643)
Gepubliceerd in: (2025)

Figure 4 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
door: David Milewski (15050643)
Gepubliceerd in: (2025)

Figure 5 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
door: David Milewski (15050643)
Gepubliceerd in: (2025)

Figure 6 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
door: David Milewski (15050643)
Gepubliceerd in: (2025)

Supplementary Table S1-S3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
door: David Milewski (15050643)
Gepubliceerd in: (2025)

Supplementary Tables S1-S5 from Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era
door: Josephine K. Dermawan (17079555)
Gepubliceerd in: (2025)

Supplementary Data 1 from Monitoring Sarcoma Response to Immune Checkpoint Inhibition and Local Cryotherapy with Circulating Tumor DNA Analysis
door: Nam Q. Bui (14958210)
Gepubliceerd in: (2025)

Supplementary Table S3 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
door: Caleb N. Seavey (15056489)
Gepubliceerd in: (2025)

Supplementary Table S4 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
door: Caleb N. Seavey (15056489)
Gepubliceerd in: (2025)

Supplementary Dataset S1 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
door: Srivandana Akshintala (16610490)
Gepubliceerd in: (2025)

Supplementary Table S5 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
door: Srivandana Akshintala (16610490)
Gepubliceerd in: (2025)

Supplementary File 1 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
door: Michael P. Ludwig (16721187)
Gepubliceerd in: (2025)

Supplementary File 2 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
door: Michael P. Ludwig (16721187)
Gepubliceerd in: (2025)

Supplementary File 3 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
door: Michael P. Ludwig (16721187)
Gepubliceerd in: (2025)

Supplementary File 4 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
door: Michael P. Ludwig (16721187)
Gepubliceerd in: (2025)

Supplementary File 5 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
door: Michael P. Ludwig (16721187)
Gepubliceerd in: (2025)

Supplementary File 6 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
door: Michael P. Ludwig (16721187)
Gepubliceerd in: (2025)

Supplementary File 7 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
door: Michael P. Ludwig (16721187)
Gepubliceerd in: (2025)

Supplementary File 8 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
door: Michael P. Ludwig (16721187)
Gepubliceerd in: (2025)

Supplementary Figure 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
door: Tom Wei-Wu Chen (15053003)
Gepubliceerd in: (2025)

Supplementary Figure 2 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
door: Tom Wei-Wu Chen (15053003)
Gepubliceerd in: (2025)

Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
door: Tom Wei-Wu Chen (15053003)
Gepubliceerd in: (2025)

Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
door: Tom Wei-Wu Chen (15053003)
Gepubliceerd in: (2025)

Supplementary Table 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
door: Tom Wei-Wu Chen (15053003)
Gepubliceerd in: (2025)

Figure S1 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
door: Upendra Kumar Soni (15051683)
Gepubliceerd in: (2025)

Figure S2 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
door: Upendra Kumar Soni (15051683)
Gepubliceerd in: (2025)

Figure S3 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
door: Upendra Kumar Soni (15051683)
Gepubliceerd in: (2025)

Figure S4 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
door: Upendra Kumar Soni (15051683)
Gepubliceerd in: (2025)

Figure S5 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
door: Upendra Kumar Soni (15051683)
Gepubliceerd in: (2025)

Figure S6 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
door: Upendra Kumar Soni (15051683)
Gepubliceerd in: (2025)

Supplementary Data File S1 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
door: Upendra Kumar Soni (15051683)
Gepubliceerd in: (2025)

Supplementary Tables from Targeting BCL6 in Gastrointestinal Stromal Tumor Promotes p53-Mediated Apoptosis to Enhance the Antitumor Activity of Imatinib
door: Xiangyu Zeng (17314920)
Gepubliceerd in: (2025)

Video 1_Imaging-driven diagnosis of retroperitoneal psoas major alveolar soft part sarcoma: a case report.mp4
door: Shasha Wei (1555588)
Gepubliceerd in: (2025)

TableS1 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
door: Tingting Liu (15386915)
Gepubliceerd in: (2025)

TableS2 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
door: Tingting Liu (15386915)
Gepubliceerd in: (2025)

TableS3 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
door: Tingting Liu (15386915)
Gepubliceerd in: (2025)

TableS4 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
door: Tingting Liu (15386915)
Gepubliceerd in: (2025)

TableS5 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
door: Tingting Liu (15386915)
Gepubliceerd in: (2025)

Supplementary Table S1 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
door: Dongliang Leng (17079663)
Gepubliceerd in: (2025)

Cannot write session to /tmp/vufind_sessions/sess_s04pd0kin1l8t8ond769uk25sf